Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

[Hyperprolactinemia in mentally ill patients].

Carvalho MM, Góis C.

Acta Med Port. 2011 Nov-Dec;24(6):1005-12. Epub 2012 Feb 20. Review. Portuguese.

2.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Haddad PM, Wieck A.

Drugs. 2004;64(20):2291-314. Review.

PMID:
15456328
3.

[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C.

Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Review. French.

PMID:
23928066
4.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
5.

[Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].

Riecher-Rössler A, Schmid C, Bleuer S, Birkhäuser M.

Neuropsychiatr. 2009;23(2):71-83. German.

PMID:
19573500
6.

Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.

Lu ML, Shen WW, Chen CH.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1978-81. doi: 10.1016/j.pnpbp.2008.09.016. Epub 2008 Sep 30.

PMID:
18848860
7.

Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.

Keller R, Mongini F.

Neurol Sci. 2002 Dec;23(5):233-5.

PMID:
12522680
8.

Antipsychotic-induced hyperprolactinemia and sexual dysfunction.

Compton MT, Miller AH.

Psychopharmacol Bull. 2002 Winter;36(1):143-64. Review.

PMID:
12397853
9.

Prolactin awareness: an essential consideration for physical health in schizophrenia.

Montejo AL.

Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14. doi: 10.1016/j.euroneuro.2008.02.004. Review.

PMID:
18346598
10.

Antipsychotic-induced hyperprolactinemia.

Bostwick JR, Guthrie SK, Ellingrod VL.

Pharmacotherapy. 2009 Jan;29(1):64-73. doi: 10.1592/phco.29.1.64. Review.

11.

Hyperprolactinemia associated with psychotropics--a review.

Madhusoodanan S, Parida S, Jimenez C.

Hum Psychopharmacol. 2010 Jun-Jul;25(4):281-97. doi: 10.1002/hup.1116. Review.

PMID:
20521318
12.

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

O'Keane V, Meaney AM.

J Clin Psychopharmacol. 2005 Feb;25(1):26-31.

PMID:
15643097
13.

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.

Halbreich U, Kinon BJ, Gilmore JA, Kahn LS.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:53-67. Review.

PMID:
12504072
14.

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

Wong-Anuchit C.

Perspect Psychiatr Care. 2016 Apr;52(2):145-52. doi: 10.1111/ppc.12111. Epub 2015 Mar 13.

PMID:
25772527
15.

The effects of atypical antipsychotics on serum prolactin levels.

Hamner M.

Ann Clin Psychiatry. 2002 Sep;14(3):163-73. Review.

PMID:
12585566
17.

Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.

Park YM, Lee SH, Lee BH, Lee KY, Lee KS, Kang SG, Lee HY, Kim W.

Psychiatry Res. 2016 May 30;239:184-9. doi: 10.1016/j.psychres.2016.03.015. Epub 2016 Mar 8.

PMID:
27010188
18.

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.

Kinon BJ, Gilmore JA, Liu H, Halbreich UM.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:55-68.

PMID:
12650681
19.

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Peuskens J, Pani L, Detraux J, De Hert M.

CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3. Review.

20.

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

Holt RI.

J Psychopharmacol. 2008 Mar;22(2 Suppl):28-37. doi: 10.1177/0269881107087951. Review.

PMID:
18477618

Supplemental Content

Support Center